Nigeria faces a growing antimicrobial resistance crisis as unregulated antibiotic use threatens health and strains hospitals nationwide.

Nigeria is confronting a critical public health challenge as antimicrobial resistance intensifies, with unregulated antibiotic use driving infections that are increasingly difficult to treat.

Also read: Nigeria’s Task Systems Honoured in USA with Microsoft Best Partner Award

The warning comes during World Antimicrobial Resistance Awareness Week, observed from November 18–24, 2025, under the theme Act Now: Protect Our Present, Secure Our Future.

Also read:

Experts report that more than 260,000 deaths in Nigeria were linked to antimicrobial resistance in 2019, with hospitals documenting resistance rates of 67.8 per cent for methicillin-resistant Staphylococcus aureus and 28.6 per cent for carbapenem-resistant Enterobacterales.

Infants and underserved communities are disproportionately affected, with sepsis cases rising amid widespread misuse of antibiotics.

One of the main drivers of resistance is the easy over-the-counter sale of potent antibiotics such as amoxicillin, ciprofloxacin, tetracycline, and metronidazole.

Despite regulations by the National Agency for Food and Drug Administration and Control classifying these drugs as prescription-only, enforcement remains minimal.

Citizens often self-medicate for malaria, diarrhoea, coughs, or vague body pains, frequently stopping courses prematurely.

Counterfeit and substandard drugs further exacerbate the problem, and economic barriers make formal healthcare access costly.

Public misconceptions, portraying antibiotics as universal “cure-all” remedies, compound the spread of resistance.

Experts estimate that 60,000 Nigerians die annually from AMR-related infections, straining hospitals and threatening long-term public health gains.

NAFDAC has intensified surveillance, issued alerts about unsafe drugs, and cracked down on open markets in cities including Lagos, Kano, and Onitsha.

However, the persistent availability of antibiotics without prescriptions highlights an urgent enforcement gap.

Health authorities advocate a multi-pronged strategy, including a national “Prescribe to Protect” campaign to verify prescriptions digitally, link pharmacy licensing to compliance, and deploy community-based enforcement teams.

Public education campaigns in local languages, social media engagement, and market-day outreach are recommended to inform Nigerians that antibiotics do not treat viral infections like malaria or the common cold.

Formalising drug distribution, retraining patent medicine vendors, and phasing out open-market sales are also central to curbing antimicrobial resistance.

Experts stress that without decisive action, AMR threatens to reverse decades of public health progress in Nigeria.

“AMR is not waiting for us to catch up,” said one public health specialist.

Also read:  UNAIDS Warns Nigeria Condom Distribution Fell 55%

“With digital verification, enforcement incentives, public engagement, and market reform, Nigeria can turn the tide. The future of our antibiotics—and our health—depends on bold action now.”